TCMK-1
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
The TCMK-1 cell line is a mouse renal tubular cell line originally derived from C3H mouse kidney tissue through SV-40 transformation.
These cells exhibit a positive expression of SV40 T-antigen and possess a karyotype model number of 78, while ranging from 64 to 157, with most cells having 2-6 acrocentric chromosomes featuring secondary constrictions, along with 1-4 biarmed chromosomes per cell. Additionally, around 60% of the cells carry one or more minute chromosomes. It is recommended to subculture TCMK-1 cells at a ratio of 1:2 to 1:8 and renew the medium every 2 to 3 days to maintain their growth and viability.
Why choose TCMK-1 from AcceGen?
The TCMK-1 cells from AcceGen exhibit high viability and exceptional quality, ensuring reliable research outcomes. These cells are cryopreserved by experienced operators and undergo rigorous quality control measures. When incubated under optimal conditions, TCMK-1 cells provide a robust and dependable platform for various experimental applications.
| Product Code | TCMK1; Transformed C3H Mouse Kidney-1 |
| Species | Mouse-Weanling, Mus Musculus |
| Cat.No | ABC-TC1224 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Kidney |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Kidney Cell Lines |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
The TCMK-1 cell line serves as a valuable tool in various research applications related to renal injury, including investigations into mitochondrial injury, hypoxia/reoxygenation injury, and sepsis-induced acute kidney injury. Its utility extends to drug development endeavors aimed at preventing or ameliorating injury and inhibiting renal tubular cell apoptosis. TCMK-1 cells also play a crucial role in elucidating related regulation pathways, thereby supporting the development of alternative treatments for acute kidney injury, making them a pivotal resource in advancing our understanding and management of kidney-related pathologies.
